Anaphylaxis risk factors

Jump to navigation Jump to search

Anaphylaxis Microchapters


Patient Information


Historical Perspective




Differentiating Anaphylaxis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis


History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Anaphylaxis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Anaphylaxis risk factors

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Anaphylaxis risk factors

CDC on Anaphylaxis risk factors

Anaphylaxis risk factors in the news

Blogs on Anaphylaxis risk factors

Directions to Hospitals Treating Anaphylaxis

Risk calculators and risk factors for Anaphylaxis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Dushka Riaz, MD


Common risk factors in the development of anaphylaxis include those related to age, sex, exposure, and other comorbid conditions such as asthma. Delayed use of epinephrine to treat anaphylaxis places patients at increased risk of being hospitalized whereas timely use decreases this risk. [1] Patients that have features of increased risk towards anaphylaxis should be advised to carry auto-injectable epinephrine. [2]

Risk Factors

Common risk factors in the development of anaphylaxis include age, sex, geography, history of asthma, atopic history, and interruption of medication.[3] [4] [5] [6] [7]

Common Risk Factors

Less Common Risk Factors


  1. Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID DOI: Check |pmid= value (help).
  2. Commins SP (2017). "Outpatient Emergencies: Anaphylaxis". Med Clin North Am. 101 (3): 521–536. doi:10.1016/j.mcna.2016.12.003. PMC 5381731. PMID 28372711.
  3. LoVerde D, Iweala OI, Eginli A, Krishnaswamy G (2018). "Anaphylaxis". Chest. 153 (2): 528–543. doi:10.1016/j.chest.2017.07.033. PMC 6026262. PMID 28800865.
  4. Theoharides TC, Valent P, Akin C (2015). "Mast Cells, Mastocytosis, and Related Disorders". N Engl J Med. 373 (2): 163–72. doi:10.1056/NEJMra1409760. PMID 26154789.
  5. Akin C (2017). "Mast cell activation syndromes". J Allergy Clin Immunol. 140 (2): 349–355. doi:10.1016/j.jaci.2017.06.007. PMID 28780942.
  6. Metcalfe DD, Schwartz LB (2009). "Assessing anaphylactic risk? Consider mast cell clonality". J Allergy Clin Immunol. 123 (3): 687–8. doi:10.1016/j.jaci.2009.02.003. PMC 2782434. PMID 19281912.
  7. Simons FE, Ardusso LR, Bilò MB, El-Gamal YM, Ledford DK, Ring J; et al. (2011). "World Allergy Organization anaphylaxis guidelines: summary". J Allergy Clin Immunol. 127 (3): 587-93.e1-22. doi:10.1016/j.jaci.2011.01.038. PMID 21377030.

Template:WH Template:WS


Template:WikiDoc Sources CME Category::Cardiology